{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T11:55:55Z","timestamp":1783857355969,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2016-I2M-3-010"],"award-info":[{"award-number":["2016-I2M-3-010"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jchromb.2018.05.048","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T02:22:57Z","timestamp":1527733377000},"page":"72-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Microdialysis combined with RRLC\u2013MS\/MS for the pharmacokinetics of two major alkaloids of Bi qi capsule and the potential roles of P-gp and BCRP on their penetration"],"prefix":"10.1016","volume":"1092","author":[{"given":"Tiankun","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2018.05.048_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/328642","article-title":"Effectiveness and safety of manufactured Chinese herbal formula for knee osteoarthritis: insights from a systematic review","volume":"2015","author":"Zhu","year":"2015","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11011-016-9894-y","article-title":"Investigation of the protective effect of Paeonia lactiflora on Semen Strychni-induced neurotoxicity based on monitoring nine potential neurotoxicity biomarkers in rat serum and brain tissue","volume":"32","author":"Shi","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijbiomac.2015.03.017","article-title":"Cytotoxicity and DNA interaction of brucine and strychnine-Two alkaloids of semen strychni","volume":"77","author":"Liu","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1248\/bpb.19.127","article-title":"Processing of nux vomica. VII. Antinociceptive effects of crude alkaloids from the processed and unprocessed seeds of Strychnos nux-vomica in mice","volume":"19","author":"Cai","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0378-8741(03)00224-1","article-title":"Analgesic and anti-inflammatory properties of brucine and brucine N-oxide extracted from seeds of Strychnos nux-vomica","volume":"88","author":"Yin","year":"2003","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0030","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1248\/yakushi.131.721","article-title":"HPLC determination of strychnine and brucine in rat tissues and the distribution study of processed semen strychni","volume":"131","author":"Chen","year":"2011","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.jchromb.2018.05.048_bb0035","series-title":"Forensic Toxicology","author":"Huang","year":"2004"},{"key":"10.1016\/j.jchromb.2018.05.048_bb0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0169-409X(00)00104-6","article-title":"Microdialysis in the study of drug transporters in the CNS","volume":"45","author":"Sawchuk","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0045","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1476-5381.2012.01858.x","article-title":"Inhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats","volume":"166","author":"O'Brien","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0169-409X(00)00107-1","article-title":"Methodological issues in microdialysis sampling for pharmacokinetic studies","volume":"45","author":"de Lange","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0055","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s11095-006-9206-z","article-title":"AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives","volume":"24","author":"Chaurasia","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0060","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0022-3565(24)34974-2","article-title":"Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities","volume":"290","author":"Dantzig","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ijc.10792","article-title":"Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979","volume":"103","author":"Shepard","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jchromb.2018.05.048_bb0070","first-page":"417","article-title":"Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C","volume":"1","author":"Allen","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002083","article-title":"Predicting binding to p-glycoprotein by flexible receptor docking","volume":"7","author":"Dolghih","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054349","article-title":"Inhibition of P-glycoprotein by HIV protease inhibitors increases intracellular accumulation of berberine in murine and human macrophages","volume":"8","author":"Zha","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jchromb.2018.05.048_bb0085","first-page":"5","article-title":"Effect of melatonin on release of beta-endorphin, norepinephrine and 5-hydroxytryptamine in rat brain","volume":"36","author":"Yu","year":"2001","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.jchromb.2018.05.048_bb0090","first-page":"1661","article-title":"Study on brain pharmacokinetics of S-ornidazole after oral administration in rats by microdialysis","volume":"46","author":"Shi","year":"2011","journal-title":"Chin. Pharm. J."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jep.2016.02.027","article-title":"Pharmacokinetic profiles of the five isoflavonoids from Pueraria lobata roots in the CSF and plasma of rats","volume":"184","author":"Xiao","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0100","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1208\/s12248-012-9366-1","article-title":"Physiologically based pharmacokinetic modeling to investigate regional brain distribution kinetics in rats","volume":"14","author":"Westerhout","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/2045-8118-11-25","article-title":"Effect of transporter inhibition on the distribution of cefadroxil in rat brain","volume":"11","author":"Chen","year":"2014","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jchromb.2018.05.048_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0378-5173(97)00290-1","article-title":"Assessment of the recovery of three lipophilic psoralens by microdialysis: an in vitro study","volume":"161","author":"Mary","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.brainresbull.2012.01.002","article-title":"Verification of brain penetration of the unbound fraction of a novel HER2\/EGFR dual kinase inhibitor (TAK-285) by microdialysis in rats","volume":"87","author":"Erdo","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jneumeth.2012.06.010","article-title":"Approach to reduce the non-specific binding in microdialysis","volume":"209","author":"Nirogi","year":"2012","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.jchromb.2018.05.048_bb0125","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s11095-006-9206-z","article-title":"AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives","volume":"24","author":"Chaurasia","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0130","article-title":"Toxicokinetics of strychnine and brucine after the oral administration of Biqi capsule to rats by RRLC-MS\/MS","author":"Zheng","year":"2017","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0135","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.talanta.2007.07.027","article-title":"Quantitative liquid chromatography\/mass spectrometry for the analysis of microdialysates","volume":"74","author":"Lanckmans","year":"2008","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2018.05.048_bb0140","first-page":"2198","article-title":"Validation ofbioanalytical LC\u2013MS\/MS assays: evaluation of matrix effects","volume":"B877","author":"Van Eeckhaut","year":"2009","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2015.11.012","article-title":"LC-MS\/MS determination and comparative pharmacokinetics of strychnine, brucine and their metabolites in rat plasma after intragastric administration of each monomer and the total alkaloids from Semen Strychni","volume":"1008","author":"Lin","year":"2016","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0150","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpba.2012.03.001","article-title":"Quantitative determination and pharmacokinetic study of the novel anti-Parkinson's disease candidate drug FLZ in rat brain by high performance liquid chromatography-tandem mass spectrometry","volume":"66","author":"Hou","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0155","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1124\/jpet.109.154781","article-title":"P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib","volume":"330","author":"Chen","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0160","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1124\/dmd.105.006536","article-title":"Dependence of nelfinavir brain uptake on dose and tissue concentrations of the selective P-glycoprotein inhibitor zosuquidar in rats","volume":"34","author":"Anderson","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0165","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00280-003-0720-y","article-title":"The influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice","volume":"53","author":"Kemper","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0170","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2012.06.032","article-title":"Influence of P-glycoprotein on brucine transport at the in vitro blood-brain barrier","volume":"690","author":"Xu","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0175","first-page":"1","article-title":"In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions","volume":"7","author":"Shityakov","year":"2014","journal-title":"Adv. Appl. Bioinforma. Chem."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0180","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.bmc.2013.12.022","article-title":"Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication","volume":"22","author":"Munagala","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jchromb.2018.05.048_bb0185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.taap.2013.12.015","article-title":"Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp","volume":"275","author":"Li","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217321463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217321463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T22:06:16Z","timestamp":1751666776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023217321463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":37,"alternative-id":["S1570023217321463"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.05.048","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microdialysis combined with RRLC\u2013MS\/MS for the pharmacokinetics of two major alkaloids of Bi qi capsule and the potential roles of P-gp and BCRP on their penetration","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.05.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}